List of autoimmune diseases
This article provides a list of
- Confirmed - Used for conditions that have strong, well-established evidence of autoimmune etiology.
- Probable - Used for conditions where there is substantial evidence of autoimmune involvement, but the scientific consensus may not be as strong as for those in the 'confirmed' category.
- Possible - Used for conditions that have some evidence pointing towards autoimmune involvement, but it's not yet clear or there is ongoing debate.
- Uncertain - Used for conditions where the evidence of autoimmune involvement is limited or contested.
Integumentary system
The
Disease | Primary organ/body part affected | Autoantibodies | Acceptance as an autoimmune disease | Prevalence rate (US) | Cit. |
---|---|---|---|---|---|
Alopecia areata | Hair follicles
|
None specific | Confirmed | 2.1% | [1][2] |
Autoimmune angioedema | Skin | C1 inhibitor
|
Probable | Less than 5,000 | [3] |
Autoimmune progesterone dermatitis | Skin | Progesterone | Probable | Extremely rare | [4] |
Autoimmune urticaria | Skin | IgE receptor
|
Probable | Not well established | [5][6] |
Bullous pemphigoid | Skin | Anti-BP180, Anti-BP230 | Confirmed | 6-30 per 100,000 (mostly older adults) | [7] |
Cicatricial pemphigoid
|
Mucous membranes, sometimes skin | Anti-BP180, Anti-BP230 | Confirmed | Rare | [8] |
Dermatitis herpetiformis | Skin | Anti-tissue transglutaminase | Confirmed | 10 per 100,000 | [9] |
Dermatomyositis | Skin and muscles
|
Anti-Jo1, Anti-Mi2, Anti-SRP, Anti-TIF1 | Confirmed | 9 in 1,000,000 | [10] |
Discoid lupus erythematosus | Skin | ANA, Anti-dsDNA, Anti-Sm | Confirmed | Part of SLE prevalence (20-150 per 100,000) | [11] |
Epidermolysis bullosa acquisita | Skin | Anti-type VII collagen | Confirmed | Extremely rare | [12] |
Erythema nodosum | Skin | None specific | Possible | Not well established | [13] |
Gestational pemphigoid | Skin | Anti-BP180, Anti-BP230 | Confirmed | Rare | [14] |
Hidradenitis suppurativa | Skin | None specific | Uncertain | 1-4% | [15] |
Lichen planus | Skin, mucous membranes | None specific | Probable | 1% | [16] |
Lichen sclerosus | Skin | None specific | Probable | Rare | [17] |
Linear IgA disease
|
Skin | Anti-epidermal basement membrane IgA | Confirmed | Extremely rare | [18] |
Morphea | Skin | None specific | Probable | Not well established | [19] |
Psoriasis | Skin | Various, not specific | Confirmed | 2-3% | [20] |
Pemphigus vulgaris | Skin and mucous membranes | Anti-desmoglein 3, Anti-desmoglein 1 | Confirmed | 1-5 per 100,000 | [21] |
Scleroderma (systemic sclerosis) | Skin, organs | ANA, anti-Scl-70, anti-centromere | Confirmed | 240 per 1,000,000 | [22] |
Vitiligo | Skin | Various, not specific | Confirmed | 1% | [23] |
Digestive system
Autoimmune disease | Primary organ/body part affected | Autoantibodies | Acceptance as an autoimmune disease | Prevalence rate (US) | Cit. |
---|---|---|---|---|---|
Autoimmune enteropathy | Small intestine | Anti-enterocyte antibodies | Probable | Rare | [24] |
Autoimmune hepatitis | Liver | ANA, ASMA, anti-LKM1 | Confirmed | 1 in 10,000 to 1 in 50,000 | [25] |
Celiac disease
|
Small intestine | Anti-tissue transglutaminase antibodies (tTG), Endomysial antibody (EMA), Deamidated gliadin peptide (DGP) | Confirmed | 1 in 100 | [26] |
Crohn's disease | Digestive tract | ASCA, Anti-OmpC, Anti-CBir1, ANCA | Probable | 201 per 100,000 adults | [27] |
Pernicious anemia | Stomach | Anti-IF, Anti-parietal cell | Confirmed | 0.1% | [28] |
Ulcerative colitis | Colon and rectum | pANCA, ASCA | Probable | 249 per 100,000 adults | [29] |
Heart and vascular system
Autoimmune disease | Primary organ/body part affected | Autoantibodies | Acceptance as an autoimmune disease | Prevalence rate (US) | Cit. |
---|---|---|---|---|---|
Rheumatic heart disease
|
Heart valves
|
Anti-streptolysin O (ASO), anti-DNase B | Confirmed | Declining due to improved treatment of strep throat | [30] |
Kawasaki disease | Coronary arteries | Unknown | Probable | 20 per 100,000 children under age 5 | [31] |
Giant cell arteritis | Large and medium arteries , can affect coronary arteries
|
None specific | Confirmed | 200 per 100,000 (over age 50) | [32][33] |
Takayasu's arteritis | Large arteries, including the aorta | None specific | Confirmed | Rare, more common in East Asia | [33][34] |
Behçet's disease | Small to large vessels in mouth, genitals, eyes, skin | None specific | Probable | [35] | |
Eosinophilic granulomatosis with polyangiitis (EGPA) | Small to medium vessels in respiratory tract, skin, heart, kidneys, nerves | ANCA | Confirmed | [36] | |
Granulomatosis with polyangiitis (GPA) | Small to medium vessels in respiratory tract, kidneys | c-ANCA/PR3-ANCA | Confirmed | [36] | |
IgA vasculitis (IgAV)
|
Small vessels in skin, joints, kidneys, gastrointestinal tract | IgA immune complexes | Probable | [37] | |
Leukocytoclastic vasculitis
|
Small vessels in skin | Various immune complexes | Probable | [38] | |
Lupus vasculitis | Small to medium vessels in multiple organs | ANA, anti-dsDNA, anti-Smith, others | Confirmed | [39] | |
Rheumatoid vasculitis | Small to medium vessels in skin, nerves, eyes, heart | Rheumatoid factor, ACPA | Probable | [40] | |
Microscopic polyangiitis (MPA) | Small vessels in kidneys, lungs, nerves, skin | p-ANCA/MPO-ANCA | Confirmed | [41] | |
Polyarteritis nodosa (PAN) | Medium to small vessels in kidneys, skin, muscles, joints, nerves | None specific | Probable | [42] | |
Polymyalgia rheumatica | Large to medium vessels in shoulders, hips | None specific | Possible | [43] | |
Urticarial vasculitis | Small vessels in skin | C1q antibodies | Probable | [44] | |
Vasculitis | All vessel sizes in multiple organs | Depends on specific type | Uncertain | [45] |
Urinary system
Autoimmune disease | Primary organ/body part affected | Autoantibodies | Acceptance as an autoimmune disease | Prevalence rate (US) | Cit. |
---|---|---|---|---|---|
Goodpasture syndrome | lungs
|
Anti-GBM antibodies | Confirmed | 1 per million people | [46] |
IgA nephropathy | Kidneys
|
IgA autoantibodies | Confirmed | 3.5 per 100,000 | [47] |
Membranous nephropathy
|
Kidneys
|
Anti-PLA2R antibodies | Confirmed | 10 per 100,000 | [48] |
Lupus nephritis | Kidneys
|
Anti-dsDNA, Anti-Sm, Anti-nuclear antibodies | Confirmed | Up to 60% of those with Lupus | [49] |
Interstitial nephritis | Kidneys
|
Various autoantibodies | Probable | Varies widely, often drug-induced | [50] |
Interstitial cystitis | Bladder | Anti-urothelial and anti-nuclear antibodies | Probable | 100-450 per 100,000 women, less common in men | [51] |
Primary sclerosing cholangitis | Bile ducts, can affect gallbladder
|
P-ANCA, Anti Smooth Muscle Antibodies (ASMA) | Confirmed | 1 per 100,000 | [52] |
Nervous system
Autoimmune disease | Primary organ/body part affected | Autoantibodies | Acceptance as an autoimmune disease | Prevalence rate (US) | Cit. |
---|---|---|---|---|---|
Acute disseminated encephalomyelitis | Central nervous system | Unknown | Confirmed | 0.8 per 100,000 | [53] |
Acute motor axonal neuropathy | Peripheral nerves
|
Anti-GM1 | Confirmed | Part of Guillain-Barré syndrome prevalence | [54] |
Anti-NMDA receptor encephalitis | Brain | Anti-NMDA receptor | Confirmed | 1.5 per million | [55] |
Autoimmune encephalitis | Brain | Various, depending on subtype (e.g., NMDA receptor antibodies, LGI1 antibodies) | Confirmed | Rare | [56] |
Balo concentric sclerosis | Central nervous system | Unknown | Probable | Rare | [57] |
Bickerstaff's encephalitis
|
Brain | Anti-GQ1b | Confirmed | Rare | [58] |
Chronic inflammatory demyelinating polyneuropathy | Peripheral nerves | Various, including anti-MAG | Confirmed | 1-2 per 100,000 | [59] |
Guillain-Barré syndrome
|
Peripheral nerves | Various, including anti-GM1, anti-GD1a | Confirmed | 1-2 per 100,000 | [60] |
Hashimoto's encephalopathy | Brain | Anti-thyroid (TPO, Tg) | Probable | Rare | [61] |
Idiopathic inflammatory demyelinating diseases
|
Central nervous system | Varies | Probable | Varies by specific disease | [62] |
Lambert–Eaton myasthenic syndrome | Neuromuscular junction (affecting both CNS and PNS) | Anti-VGCC | Confirmed | 0.5-2 per million | [63] |
Multiple sclerosis | Central nervous system | Unknown, but Oligoclonal bands often present in CSF | Confirmed | 90 per 100,000 | [64] |
Myasthenia gravis | Neuromuscular junction (affecting both CNS and PNS) | Anti-AChR, anti-MuSK | Confirmed | 20 per 100,000 | [65] |
NMOSD
|
Optic nerves and spinal cord | AQP4-IgG (NMO-IgG) | Confirmed | 0.5 - 4 per 100,000 | [66] |
Restless legs syndrome | Central nervous system (thought to involve dopaminergic pathways) | Unknown | Uncertain | 5-15% (more common in older adults) | [67] |
Stiff-person syndrome | Central nervous system | Anti-GAD, anti-amphiphysin | Confirmed | Rare | [68] |
Sydenham's chorea | Brain | Anti-basal ganglia | Confirmed | Rare (linked to Group A streptococcal infection) | [69] |
Transverse myelitis | Spinal cord | Various, including anti-AQP4 | Probable | 1-8 per million | [70] |
Undifferentiated connective tissue disease (UCTD) | Various | ANA (antinuclear autoantibody) (HEp-2 cells) | Confirmed | 2 per 100,000 | [71] |
Endocrine system
Autoimmune disease | Primary organ/body part affected | Autoantibodies | Acceptance as an autoimmune disease | Prevalence rate (US) | Cit. |
---|---|---|---|---|---|
Addison's disease | Adrenal glands
|
21-hydroxylase antibodies | Confirmed | 0.93-1.4 per 10,000 | [72] |
Autoimmune oophoritis | Ovaries
|
Anti-ovarian antibodies | Probable | Rare | [73] |
Autoimmune orchitis
|
Testes
|
Anti-sperm antibodies | Probable | Rare | [74] |
Autoimmune pancreatitis | Pancreas | IgG4, Anti-CA2 antibodies | Confirmed | 0.82-1.3 per 100,000 | [75] |
Autoimmune polyendocrine syndrome type 1 (APS1) | Multiple endocrine organs | Various autoantibodies depending on the organs affected | Confirmed | 1 in 100,000 to 200,000 | [76] |
Autoimmune polyendocrine syndrome type 2 (APS2) | Multiple endocrine organs | Various autoantibodies depending on the organs affected | Confirmed | 1 in 20,000 | [77] |
Autoimmune polyendocrine syndrome type 3 (APS3) | Multiple endocrine organs | Various autoantibodies depending on the organs affected | Confirmed | Rare | [77] |
Diabetes mellitus type 1
|
Pancreas | Anti-insulin, anti-IA-2, anti-GAD, anti-ZnT8 antibodies | Confirmed | 1.6 per 1,000 | [78] |
Endometriosis | Endometrium | Anti-endometrial antibodies | Probable | 6-10% of women of reproductive age | [79] |
Graves' disease | Thyroid gland
|
TSI, TPO, TG antibodies | Confirmed | 1.2% of the population | [80] |
Hashimoto's thyroiditis | Thyroid gland
|
TPO, TG antibodies | Confirmed | 5% of the population | [81] |
Ord's thyroiditis | Thyroid gland
|
TPO, TG antibodies | Confirmed | Rare | [82] |
Sjögren syndrome | Exocrine glands (salivary and lacrimal glands)
|
Anti-SSA/Ro, Anti-SSB/La antibodies | Confirmed | 0.1-4% of the population | [83] |
Respiratory system
Autoimmune disease | Primary organ/body part affected | Autoantibodies | Acceptance as an autoimmune disease | Prevalence rate (US) | Cit. |
---|---|---|---|---|---|
Goodpasture syndrome | See urinary system [a] | See urinary system | Confirmed | See urinary system | — |
Eosinophilic granulomatosis with polyangiitis (EGPA) | See vascular system [b] | See vascular system | Confirmed | See vascular system | — |
Granulomatosis with polyangiitis (GPA) | See vascular system [c] | See vascular system | Confirmed | See vascular system | — |
Idiopathic pulmonary fibrosis | Lungs | None specific | Possible | 20 per 100,000 (men), 13 per 100,000 (women) | [84] |
Interstitial lung disease | Lungs | Depends on the subtype (e.g. Anti-Jo1 in Anti-synthetase syndrome) | Probable | 31.5 per 100,000 (men), 26.1 per 100,000 (women) | [85] |
Pulmonary alveolar proteinosis | Lungs | Anti-GM-CSF antibodies | Confirmed | 6.2 per million | [86] |
Rheumatoid lung disease | Lungs | Rheumatoid factor, Anti-CCP antibodies | Confirmed | Part of RA prevalence (about 1%) | [87] |
Sarcoidosis | Lungs and other organs | None specific | Confirmed | 10 - 40 per 100,000 | [88] |
Blood
Autoimmune disease | Autoantibodies | Acceptance as an autoimmune disease | Prevalence rate (US) | Cit. |
---|---|---|---|---|
Autoimmune hemolytic anemia | Anti-red blood cell antibodies | Confirmed | 1-3 per 100,000 | [89] |
Immune thrombocytopenia
|
Anti-platelet antibodies | Confirmed | 3.3 per 100,000 (adults), 50 per 100,000 (children) | [90] |
Thrombotic thrombocytopenic purpura | ADAMTS13 autoantibodies | Confirmed | 1-2 per million | [91] |
Antiphospholipid syndrome | Antiphospholipid antibodies | Confirmed | 40-50 per 100,000 | [92] |
Paroxysmal nocturnal hemoglobinuria | None specific, mutation causes self-cells to become susceptible to attack | Possible | 1-2 per million | [93] |
Reproductive system
The reproductive system is responsible for the production and regulation of sex hormones, the formation of germ cells, and the nurturing of fertilized eggs. In women, it includes structures such as ovaries, fallopian tubes, a uterus, and a vagina, while in men, it includes testes, vas deferens, seminal vesicles, prostate, and the penis. Autoimmune diseases of the reproductive system can affect both male and female fertility and reproductive health.
Autoimmune disease | Primary organ/body part affected | Autoantibodies | Acceptance as an autoimmune disease | Prevalence rate (US) | Cit. |
---|---|---|---|---|---|
Autoimmune orchitis
|
Testes
|
Anti-sperm antibodies | Probable | Not well established | [94] |
Autoimmune oophoritis | Ovaries
|
Anti-ovarian antibodies | Probable | Not well established | [94] |
Endometriosis | Uterus, ovaries, and pelvic tissue | Various, including anti-endometrial antibodies | Probable | Approx. 10% of women of reproductive age | [95] |
Premature ovarian failure
|
Ovaries | Anti-ovarian antibodies, Anti-adrenal antibodies | Confirmed | 1% of women under 40 years | [96] |
Eyes
Autoimmune disease | Primary organ/body part affected | Autoantibodies | Acceptance as an autoimmune disease | Prevalence rate (US) | Cit. |
---|---|---|---|---|---|
Autoimmune retinopathy | Retina | Various | Confirmed | [97] | |
Autoimmune uveitis
|
Uvea | Various | Confirmed | [98] | |
Cogan syndrome | Inner ear and eye | None specific | Probable | [99] | |
Graves' ophthalmopathy | Eye muscles and connective tissue | TSH receptor antibodies
|
Confirmed | [100] | |
Intermediate uveitis | Uvea (pars plana) | Various | Probable | [101] | |
Ligneous conjunctivitis | Conjunctiva | Plasminogen deficiency
|
Possible | Rare | [102] |
Mooren's ulcer | Cornea | None specific | Probable | Rare | [103] |
Neuromyelitis optica
|
Optic nerve and spinal cord | Anti-AQP4 | Confirmed | [104] | |
Opsoclonus myoclonus syndrome | Central nervous system, eye movement control | Anti-neuronal antibodies | Possible | [105] | |
Optic neuritis | Optic nerve | Various | Confirmed | [106] | |
Scleritis | Sclera | Various | Possible | [107] | |
Susac's syndrome | Retina, cochlea, and brain | None specific | Probable | [108] | |
Sympathetic ophthalmia | Uveal tract
|
Various | Probable | Rare | [109] |
Tolosa–Hunt syndrome | Orbit | None specific | Uncertain | Rare | [110] |
Muscular system
These autoimmune diseases are primarily associated with the muscles and neuromuscular function.
Autoimmune disease | Primary organ/body part affected | Autoantibodies | Acceptance as an autoimmune disorder | Prevalence rate (US) | Cit. |
---|---|---|---|---|---|
Dermatomyositis | See integumentary system [d] | See integumentary system | Confirmed | See integumentary system | — |
Fibromyalgia | Musculoskeletal system, pain perception | None specific | Possible | [111] | |
Inclusion body myositis | Proximal and distal muscles | None specific | Probable | [112] | |
Myositis | Skeletal muscles | Various, depends on subtype | Confirmed | [113] | |
Myasthenia gravis | Voluntary muscles, neuromuscular junctions | Anti-acetylcholine receptor, Anti-MuSK | Confirmed | [114] | |
Neuromyotonia | Peripheral nerves affecting muscle control | Anti-voltage-gated potassium channels | Probable | [115] | |
Paraneoplastic cerebellar degeneration | Central nervous system, cerebellum | Anti-Yo, Anti-Hu, Anti-Ri, others | Confirmed | [116] | |
Polymyositis | Proximal skeletal muscles | Anti-Jo-1, Anti-SRP, others | Confirmed | [117] |
Autoimmune comorbidities
This list includes conditions that are not diseases, but symptoms or syndromes common to autoimmune disease.[118]
- Chronic fatigue syndrome
- Complex regional pain syndrome
- Eosinophilic esophagitis
- Gastritis
- POEMS syndrome[119]
- Raynaud's phenomenon
- Primary immunodeficiency[120]
- Pyoderma gangrenosum
Non-autoimmune
At this time, there is not sufficient evidence to indicate that these diseases are caused by autoimmunity.
Disease | Reason not believed to be autoimmune | Cit. |
---|---|---|
Agammaglobulinemia
|
An immune system disorder but not an autoimmune disease. | |
Amyloidosis | No consistent evidence of association with autoimmunity. | |
Amyotrophic lateral sclerosis
|
No consistent evidence of association with autoimmunity. | |
Anti-tubular basement membrane nephritis | No consistent evidence of association with autoimmunity. | |
Atopic allergy
|
A hypersensitivity. | |
Atopic dermatitis | A hypersensitivity. | |
Autism | No consistent evidence of association with maternal autoimmunity. | |
Blau syndrome | Overlaps both sarcoidosis and granuloma annulare. No evidence of association with autoimmunity. | |
Cancer | No consistent evidence of association with autoimmunity. | |
Castleman's disease
|
An immune system disorder but not an autoimmune disease. | |
Chagas disease | No consistent evidence of association with autoimmunity. | [121] |
Chronic obstructive pulmonary disease | No consistent evidence of association with autoimmunity. | [122][123] |
Chronic recurrent multifocal osteomyelitis | LPIN2, D18S60. Synonyms: Majeed syndrome. | |
Complement component 2 deficiency
|
Possibly symptomatic of autoimmune diseases, but not a disease. | |
Congenital heart block | May be related to autoimmune activity in the mother. | |
Contact dermatitis | A hypersensitivity. | |
Cushing's syndrome | No consistent evidence of association with autoimmunity. | |
Cutaneous leukocytoclastic angiitis
|
No consistent evidence of association with autoimmunity. | |
Dego's disease
|
No consistent evidence of association with autoimmunity. | |
Eosinophilic gastroenteritis | Possibly a hypersensitivity. | |
Eosinophilic pneumonia | A class of diseases, some of which may be autoimmune. | |
Erythroblastosis fetalis
|
Mother's immune system attacks fetus. An immune system disorder but not autoimmune. | |
Fibrodysplasia ossificans progressiva | Possibly an immune system disorder but not autoimmune. | |
Gastrointestinal pemphigoid | No consistent evidence of association with autoimmunity. | |
Hypogammaglobulinemia | An immune system disorder but not autoimmune. | |
Idiopathic giant-cell myocarditis | No consistent evidence of autoimmune cause though the disease has been found comorbid with other autoimmune diseases. | [124] |
Idiopathic pulmonary fibrosis | Autoantibodies: SFTPA1, SFTPA2, TERT, and TERC. | |
IgA nephropathy | An immune system disorder but not an autoimmune disease. | |
IPEX syndrome | A genetic mutation in FOXP3 that leads to autoimmune diseases, but not an autoimmune disorder itself. | |
Ligneous conjunctivitis | No consistent evidence of association with autoimmunity. | |
Majeed syndrome | No consistent evidence of association with autoimmunity. | |
Narcolepsy | No evidence of association with autoimmunity. Research not reproducible.[needs update] | [125][126][127][128] |
Rasmussen's encephalitis
|
No consistent evidence of association with autoimmunity. | |
Schizophrenia | No consistent evidence of association with autoimmunity. | [129][130][131] |
Serum sickness | A hypersensitivity. | |
Spondyloarthropathy | No consistent evidence of association with autoimmunity. | |
Sweet's syndrome
|
No consistent evidence of association with autoimmunity. | |
Takayasu's arteritis | No consistent evidence of association with autoimmunity. | |
Undifferentiated spondyloarthropathy |
See also
Notes
- ^ For detailed information on Goodpasture syndrome, including its impact on the respiratory system, refer to its entry in the urinary system section.
- ^ For detailed information on EGPA, including its impact on the respiratory system, refer to its entry in the vascular system section.
- ^ For detailed information on GPA, including its impact on the respiratory system, refer to its entry in the vascular system section.
- ^ For detailed information on dermatomyositis, including its impact on the musclar system, refer to its entry in the integumentary system section.
References
- PMID 28300084.
- PMID 24202232.
- ^ "Acquired angioedema - About the Disease". Genetic and Rare Diseases Information Center. 2021-01-08. Retrieved 2023-07-12.
- PMID 34877200.
- S2CID 249362247.
- S2CID 78092096.
- PMID 35874745.
- PMID 34245180.
- PMID 33432477.
- PMID 34745149.
- S2CID 9050427.
- PMID 35701269.
- PMID 33683567.
- S2CID 212718889.
- S2CID 243497119.
- S2CID 52982317.
- PMID 27232363.
- PMID 34441024.
- S2CID 206776415.
- PMID 26025581.
- S2CID 199436546.
- PMID 25672301.
- S2CID 212666272.
- S2CID 221257881.
- PMID 31886312.
- S2CID 249622609.
- S2CID 13678540.
- S2CID 216129306.
- S2CID 18349657.
- PMID 27188830.
- PMID 32924089.
- S2CID 73472064.
- ^ PMID 32845392.
- S2CID 21279076.
- PMID 30984205.
- ^ S2CID 253087925.
- S2CID 235635414.
- PMID 33713282.
- S2CID 221329029.
- S2CID 259957955.
- PMID 25992801.
- S2CID 246296626.
- PMID 35612524.
- PMID 34222586.
- S2CID 250323897.
- S2CID 257836514.
- PMID 34642783.
- S2CID 59275094.
- PMID 27821390.
- PMID 9135830.
- S2CID 58586665.
- PMID 28802875.
- PMID 33153097.
- S2CID 208275682, retrieved 2023-11-27
- S2CID 197464804.
- S2CID 220436473.
- S2CID 9624023.
- PMID 33378029.
- S2CID 221619303.
- S2CID 45391831.
- S2CID 39949260.
- PMID 23522777.
- PMID 36578903.
- S2CID 43931137.
- S2CID 19615369.
- PMID 33009077.
- S2CID 52335655.
- PMID 35717735.
- S2CID 31037155.
- PMID 23186897.
- PMID 37461764.
- PMID 32063488.
- S2CID 260246899.
- PMID 24424181.
- PMID 36293522.
- PMID 35690244.
- ^ PMID 29562162.
- S2CID 231938319.
- PMID 35805112.
- PMID 25777757.
- PMID 35743024.
- S2CID 8184654.
- S2CID 263009504.
- S2CID 205152247.
- PMID 34168062.
- S2CID 73484878.
- S2CID 246496520.
- PMID 35680449.
- S2CID 247428832.
- PMID 28428120.
- PMID 28768626.
- S2CID 209447261.
- PMID 33512400.
- ^ a b [citation needed]
- PMID 20574791.
- PMID 19196677.
- PMID 32823399.
- PMID 30837991.
- S2CID 219692073.
- S2CID 225173294.
- S2CID 250090138.
- S2CID 45834939.
- PMID 34130538.
- S2CID 5932243.
- S2CID 232387732.
- S2CID 252564095.
- PMID 34068884.
- PMID 33408428.
- PMID 35647958.
- PMID 31849556.
- PMID 33918736.
- S2CID 71146208.
- S2CID 41157692.
- S2CID 19615369.
- S2CID 251720232.
- PMID 34827413.
- S2CID 206296273.
- ISBN 978-0-12-384929-8.
- PMID 12456500.
- PMID 15096561.
- PMID 16446117.
- PMID 14514931.
- S2CID 1732877.
- S2CID 21558135.
- PMID 19412176.
- ^ "Narcolepsy is an autoimmune disorder, Stanford researcher says". EurekAlert. American Association for the Advancement of Science. 2009-05-03. Archived from the original on 10 May 2009. Retrieved 2009-05-31.
- PMID 11682267.
- (PDF) from the original on 14 April 2008. Retrieved 2008-03-07.
- PMID 16513876.
- S2CID 23236916.
- PMID 16997531.